Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report)’s share price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 26.50 ($0.34) and traded as low as GBX 26 ($0.33). Mereo BioPharma Group plc (MPH.L) shares last traded at GBX 26.50 ($0.34), with a volume of 49,264 shares.
Mereo BioPharma Group plc (MPH.L) Stock Performance
The company has a market capitalization of £89.76 million and a P/E ratio of -0.21. The company has a debt-to-equity ratio of 164.26, a quick ratio of 2.92 and a current ratio of 2.98. The stock has a fifty day moving average of GBX 26.50 and a 200 day moving average of GBX 26.50.
Mereo BioPharma Group plc (MPH.L) Company Profile
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Further Reading
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- What Are Dividend Contenders? Investing in Dividend Contenders
- This Small Cap Wealth Management Stock Could Provide Big Returns
- How Can Investors Benefit From After-Hours Trading
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Financial Services Stocks Investing
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
